ClinicalTrials.gg
CompletedNCT07872280Updated Oct 13, 2026

Neuromuscular Facilitation Protocol on Pain, Range and Function in KOA

An interventional study of Standard physical therapy and Neuromuscular Facilitation Protocol in Knee Osteoarthristis, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jan 2026, registered Sep 2026).
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Study summary

An individual can suffer from knee osteoarthritis, which is a degenerative condition, and while standard physical therapy can assist in some way, improved joint mechanics and decreased functional limitations can be achieved through the use of specialized methods, such as the advanced protocols of Neuromuscular Facilitation. Objective of this study is to use Neuromuscular Facilitation, a technique to investigate in terms of its effect in comparison to standard Physical therapy on the levels of pain, the range and range of motion at the joint, and the overall physical disability associated with knee osteoarthritis. An experiment that involved a randomized group of 54 subjects who were aged between 40 and 80 with Grade 2 or 3 knee osteoarthritis was conducted. Recruitment of subjects was done by way of non-probability convenience sampling at United Hospital in Faisalabad. Subjects were randomly placed in 2 groups: PNF-based neuromuscular facilitation group (Group A) received bridging, side decubits, sural triceps, sitting and standing from chair, lateral walk, going up and down stairs, squating and group B received standard Physical therapy which included cryotherapy and isometric Quadriceps strengthening and Isometric Hip adductor strengthening exercise. The outcomes were assessed using Numeric Pain Rating Scale, Goniometry for range of motion, and The Western Ontario and McMaster Universities Osteoarthritis Index.

02

Conditions studied

  • Knee Osteoarthristis

Keywords

  • knee osteoarthritis
  • Neuromuscular Facilitation
  • Range of Motion
  • Numeric Pain Rating Scale
  • WOMAC index
03

In context

Osteoarthritis, Knee

3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.

This study's enrollment of 54 is below the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,176 studies on the registry; 637 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 40 to 60 years old, men and women, with knee osteoarthritis was included.
  • Clinical diagnosis and confirmed by radiography.
  • Individuals diagnosed with Osteoarthritis knee by certified Orthopaedic surgeon.
  • Individuals having knee pain from last 3 months.
  • NPRS value of pain must be 3 to 7 during walk.
  • Individuals not involved in any other physical therapy treatment modalities during the protocol period including their follow up period.
  • Patient has knee flexion range of motion (ROM) of at least 90°.
  • Patients agree to sign written consent form.

Exclusion criteria

Exclusion Criteria:

  • Age less than 40 and more than 60 years.
  • Any other knee joint pathologies, for example, Chondromalacia patella, plica syndrome are excluded.
  • Neurological issues.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
54 participants (actual)

Study arms

  • Active comparator
    Standard Physical therapy

    Standard Physical therapy included Cryotherapy ,Isometric Quadriceps Strengthening Exercise, and Isometric Hip Adductor Strengthening Exercise.

    Other: Standard physical therapy

  • Experimental
    Neuromuscular Fcilitation Protocol

    Neuromuscular Facilitation Rehabilitation that works on PNF principal and help in strengthening of lower limbs with the help of exercise Which include bridge, side Decubitus, sural triceps, sitting and standing from chair, lateral walk, going up and down stairs and squatting.

    Other: Neuromuscular Facilitation Protocol

Interventions

  • OtherStandard physical therapy

    Standard physical therapy include Cryotherapy. That was placed on the anterior side of knee joint for 10 mintues, Isometric Quadriceps Strengthening Exercises, and Isometric Hip Adductor Strengthening Exercises. Both for Two sets of 10 repetitions.

  • OtherNeuromuscular Facilitation Protocol

    Patients received Neuromuscular Facilitation Rehabilitation that works on PNF principal and help in strengthening of lower limbs with the help of exercise. It included bridging exercise , side Decubitus, sural triceps, sitting and standing from chair. lateral walk, going up and down stairs, squatting. All these exercises have sessions two through four that worked on combination of isotonic methods. In fiirst and second weeks two sets of three repeats, in weeks three and four two sets of four repetitions.

06

What researchers measure

Primary outcomes

  1. WOMAC index for disability

    Originally validated by Dr. Nicholas Bellamy in 1988, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a disease-specific, to assess the effectiveness of treatment in patients with knee osteoarthritis. The test comprises 24 unique items that are separated into three separate functional subscales: a 17-item Physical Function domain that measures limitations during activities of daily living (ADLs), a 2-item Stiffness domain that evaluates joint restriction during waking or rest, and a 5-item Pain domain that measures mechanical discomfort during essential activities like walking or stair negotiation. The standard 5-point Likert version rates each item from 0 (None) to 4 (Extreme). This results in cumulative subscale limits of 0-20 for pain, 0-8 for stiffness, and 0-68 for physical function, which add up to a global composite score that ranges from 0 to 96, with higher values denoting more severe structural and functional degeneration.

    Time frame: 4th day

Secondary outcomes

  1. NPRS for pain score

    The NPRS is a frequently used tool for evaluating the severity of pain at a particular moment, by asking individuals to rate their discomfort on a scale value from 0 to 10, in which 0 indicates "there is no pain" and 10 indicating "very painful". In many clinical practices, the NPRS is routinely used during outpatient visits, and these scores are documented in the patient's electronic health record (EHR) to enable ongoing monitoring of pain intensity by both clinicians and researchers.

    Time frame: 4th weeks

  2. Universal Goniometer (UG) for ROM

    ROM is an important parameter for evaluation of movement limitations. While clinicians researchers use universal goniometers to measure ROM, the accuracy of the method depends on the clinician's skill and experience. The normal Knee Flexion range of motion is Stairs, chairs, and slopes that need less than 90 degrees of knee flexion 90-120 degrees and roughly 135 degrees of knee flexion in a bath

    Time frame: 4th Weeks

07

Study locations

1 site
  • United hospital Faisalabad
    Faisalabad, Punjab Province 38000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Mar 2026, 2 months.

Of 1,143 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 2 months is below that.

Counting every sponsor, half of 1,285 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2026
First posted
Oct 13, 2026
StartActual
Jan 2, 2026
Primary completionActual
Mar 4, 2026
CompletionActual
Apr 20, 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872280
Responsible party
Sponsor
First posted
Oct 13, 2026
Start date
Jan 2, 2026
Primary completion
Mar 4, 2026
Completion
Apr 20, 2026
Last update
Oct 13, 2026

Study contacts

Danish Hassan, PhD
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion